(Q91285149)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

title

Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

author name string

Jasmin Federizon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Amber Frye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Wei-Chiao Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Thomas M Hart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Xuedan He

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Christopher Beltran

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Ashley L Marcinkiewicz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Iain L Mainprize

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Yi-Pin Lin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

Jonathan F Lovell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

publication date

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

page(s)

942-950

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31727504%20AND%20SRC:MED&resulttype=core&format=json

The Spirochetal Etiology of Lyme Disease

21 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

"Ticking Bomb": The Impact of Climate Change on the Incidence of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Antigen Engineering Approaches for Lyme Disease Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Design and development of a novel vaccine for protection against Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

The Lyme vaccine: a cautionary tale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Vaccine Adjuvants: from 1920 to 2015 and Beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Liposomes as carriers of antigens and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Lipoproteins from Borrelia burgdorferi applied in liposomes and presented by dendritic cells induce CD8(+) T-lymphocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

A silicone membrane for in vitro feeding of Ixodes scapularis (Ixodida: Ixodidae).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

An in vitro feeding assay to test acaricides for control of hard ticks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Infection Rate by Trypanosoma cruzi and Biased Vertebrate Host Selection in the Triatoma dimidiata (Hemiptera: Reduvidae) Species Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Identification of Lyme borreliae proteins promoting vertebrate host blood-specific spirochete survival in Ixodes scapularis nymphs using artificial feeding chambers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Structural analysis of an outer surface protein from the Lyme disease spirochete, Borrelia burgdorferi, using circular dichroism and fluorescence spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Mechanism of action of cytochalasin B on actin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073

An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.10.073